Related Experiment Video
Updated: Dec 2, 2025

07:41
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
2.7K
Genomic control of metastasis.
Saroor A Patel1, Paulo Rodrigues1, Ludovic Wesolowski1
1MRC Cancer Unit, University of Cambridge, Hutchison/MRC Research Centre, Box 197, Cambridge Biomedical Campus, Cambridge, CB2 0XZ, UK.
British Journal of Cancer
|November 4, 2020
Summary
Metastasis, a major cause of cancer death, arises not from exclusive mutations but from oncogenes co-opting normal cellular programs. Understanding these genomic and epigenetic shifts offers new therapeutic targets for cancer spread.
Area of Science:
- Cancer Biology
- Genomics
- Epigenetics
Background:
- Metastasis is the primary cause of cancer mortality.
- The genomic underpinnings of metastatic phenotypes remain incompletely understood.
- Comparative genetic studies reveal complex evolutionary patterns in cancer dissemination.
Purpose of the Study:
- To elucidate the genomic and epigenetic mechanisms driving cancer metastasis.
- To identify how oncogenic pathways acquire metastatic capabilities.
- To explore potential therapeutic interventions targeting metastatic progression.
Main Methods:
- Comparative genetic analyses of primary and metastatic tumors.
- Investigation of whole-genome amplification in metastatic clones.
- Examination of epigenetic modifications influencing oncogenic pathway function.
Main Results:
- No metastasis-exclusive driver mutations were identified.
- Metastatic traits emerge from oncogenic pathways co-opting stem cell, developmental, and regenerative programs.
- Epigenetic mechanisms alter the functional consequences of oncogenic mutations to promote metastasis.
Conclusions:
- Cancer metastasis is driven by the reprogramming of oncogenic pathways through epigenetic alterations.
- Understanding the interaction between oncogenes and physiological programs is crucial for developing anti-metastasis strategies.
- Targeting these mechanisms offers novel therapeutic opportunities for advanced cancers.
Related Concept Videos
Metastasis
6.2K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.2K
Mitogens and the Cell Cycle
7.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.5K
In-vitro Mutagenesis
15.8K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
15.8K
Targeted Cancer Therapies
8.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.2K

